twenty-five patients with disseminated cancer ( nine with renal cell carcinoma , five with melanoma , three with hodgkin 's lymphoma and chronic myelocytic leukemia [ cml ] , two with soft tissue sarcoma , one each with large-cell lymphoma , breast cancer , and colon cancer ) , 13 males and 12 females , aged 25 to 68 , were treated with recombinant human interleukin-2 ( ril2 ) by continuous infusion and adoptive transfer of autologous lymphocytes activated in vitro with il2 .
C0007134
renal cell carcinoma
C0218986
recombinant human interleukin-2